First Republic Investment Management, Inc. Vertex Pharmaceuticals Inc Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
A detailed history of First Republic Investment Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 52,516 shares of VRTX stock, worth $26.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
52,516
Previous 33,790
55.42%
Holding current value
$26.4 Million
Previous $11.9 Million
53.57%
% of portfolio
0.05%
Previous 0.06%
Shares
25 transactions
Others Institutions Holding VRTX
# of Institutions
1,716Shares Held
225MCall Options Held
1.19MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.7MShares$13.4 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.89 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.29 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $129B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...